Back to search

Article

Allogeneic transplantation for AML with RUNX1::RUNX1T1 fusion: a time-dependent analysis in a retrospective study

2024-07-12

Abstract excerpt

<title>Abstract</title> <p>The prognostic significance of measurable residual disease (MRD) in guiding allogeneic hematopoietic cell transplantation (Allo-HCT) in acute myeloid leukemia (AML) with <italic>RUNX1::RUNX1T1</italic> fusion in first complete remission (CR1) requires further elucidation. This retrospective study analyzed 246 patients diagnosed AML with <italic>RUNX1::RUNX1T1</italic> fusion to evaluate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11a268e3-f1e7-5122-a081-76741eeb3517
DOI
10.21203/rs.3.rs-4555773/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Allogeneic transplantation for AML with RUNX1::RUNX1T1 fusion: a time-dependent analysis in a retrospective studyDOI 10.21203/rs.3.rs-4555773/v1
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.Semantic proximity
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaSemantic proximity
[Outcome of acute myeloid leukemia with FLT3-ITD mutation treated by allogeneic hematopoietic stem cell transplantation].Semantic proximity
Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationSemantic proximity
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupSemantic proximity
Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationSemantic proximity
Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort StudySemantic proximity
Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosisSemantic proximity
Allogeneic haematopoietic stem cell transplantation can improve the prognosis of high-risk paediatric t(8;21) acute myeloid leukaemia in first remission based on MRD-guided treatment.Semantic proximity
Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study.Semantic proximity
Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AMLSemantic proximity
In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification.Semantic proximity
Select a neighboring publication to make it the new centre.